John Overdeck’s Rallybio RLYB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$266K Buy
+16,619
New +$214K ﹤0.01% 4607
2026
Q1
Sell
-4,625
Closed -$25.4K 4874
2025
Q4
$25.4K Buy
4,625
+1,943
+72% +$10K ﹤0.01% 3979
2025
Q3
$10.7K Sell
2,682
-5,291
-66% -$22.2K ﹤0.01% 3622
2025
Q2
$21.6K Sell
7,973
-366
-4% -$970 ﹤0.01% 3115
2025
Q1
$43.7K Sell
8,339
-1,262
-13% -$7.97K ﹤0.01% 3057
2024
Q4
$73.7K Sell
9,601
-1,190
-11% -$9.97K ﹤0.01% 3003
2024
Q3
$101K Buy
10,791
+4,134
+62% +$39.8K ﹤0.01% 2897
2024
Q2
$71.4K Buy
+6,657
New +$90.2K ﹤0.01% 2859

Other funds holding RLYB

John Overdeck's RLYB Position: Q2 2026 in Review

John Overdeck opened a new position in Rallybio (RLYB) in Q2 2026: 16,619 shares worth $266K. The stake represents ﹤0.01% of the portfolio and ranks #4607 among its holdings. This is a return to the name: John Overdeck previously reported a position in RLYB as recently as Q4 2025.

John Overdeck first reported a position in RLYB in Q2 2024 and has held it in 8 quarters since. 37 funds tracked by Wall St. Rank hold RLYB as of Q2 2026.

  • John Overdeck held 16,619 shares of Rallybio worth $266K as of Q2 2026.
  • Rallybio was a new John Overdeck position in Q2 2026.
  • Rallybio made up ﹤0.01% of John Overdeck's portfolio in Q2 2026, its #4607 holding.
  • John Overdeck first reported a position in Rallybio in Q2 2024 and has held it in 8 quarters since.
  • 37 funds tracked by Wall St. Rank held Rallybio as of Q2 2026.

Based on Two Sigma Investments's 13F filing for Q2 2026, filed 14 Aug 2026.